As a trusted technology partner with a proven track record, we are experts in the healthcare AI space and can help add value to your portfolio.
Clinithink has been developing advanced enterprise class applications in healthcare AI for over a decade. As our partner, you can leverage that depth of expertise, to differentiate your portfolio and enhance your market offering.
We partner with market-leading organisations delivering technology-enabled solutions and services to the healthcare and life science sectors. We work closely alongside those partners, every step of the way, so that they can be sure our technology helps them provide net new value to their customers, right from the outset.
Clinithink's patented CLiX technology applies the language of doctors operating within the healthcare data ecosystem to create insights that can transform traditional healthcare data analytics and revenue enhancement.
Experts estimate that as much as 80% of the data contained within electronic medical systems is unstructured – made up of typed or dictated physician’s notes and correspondence that might include discharge letters, surgical notes and primary care notes. But this unstructured clinical narrative is incredibly valuable – it contains reams of highly relevant and richly detailed information that the structured and coded data simply does not provide.
Until now, most enterprise data investments have focused solely on structured data assets. But Clinithink’s CLiX technology offers a way of leveraging this untapped data asset – unlocking the unstructured narrative within it, re-expressing that narrative as structured information, facilitating a deeper understanding of healthcare data, and thereby enabling more robust data-driven decisions that improve the efficiency and effectiveness of care delivery.
The insights CLiX applications provide are enabling our partners to offer value-added data analytics and data science consulting services such as cohort matching, predictive modelling, risk assessment, revenue optimisation or population-based healthcare needs assessment.
The one thing all our customers and partners share is a need for innovative data-driven solutions that can help change the healthcare landscape.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.
Healthix is the largest public Health Information Exchange (HIE) in the USA, serving the New York downstate region, including New York City and Long Island. Healthix collect data from more than 8,000 Healthcare Facilities for over 20 million patients.
Alexion's mission is to transform the lives of people living with rare diseases and devastating conditions through the development and delivery of innovative medicines, as well as through supportive technologies and healthcare services.